Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

TRIM30B Inhibitors

Chemical inhibitors of tripartite motif-containing 30B (TRIM30B) include a range of compounds that target various biochemical and cellular pathways, which can lead to the functional inhibition of this protein. MG132, a proteasome inhibitor, can prevent the degradation of ubiquitinated proteins, a process in which TRIM30B is implicated due to its role in ubiquitination and subsequent proteasomal degradation. Similarly, bortezomib and epoxomicin serve as selective proteasome inhibitors, possibly leading to an accumulation of proteins that regulate or interact with TRIM30B, thus inhibiting the protein's function. Lactacystin, another irreversible proteasome inhibitor, can also inhibit the degradation of regulatory proteins associated with TRIM30B, thereby indirectly inhibiting its activity.

Chloroquine, known for raising lysosomal pH, can interfere with lysosomal degradation where TRIM30B might be localized for breakdown, leading to its functional inhibition. Cycloheximide, by inhibiting eukaryotic protein biosynthesis, can prevent the synthesis of TRIM30B in cells where it is actively being produced. Leupeptin, an inhibitor of serine, cysteine, and threonine peptidases, can hinder protease activity that processes proteins interacting with TRIM30B, contributing to the inhibition of TRIM30B activity. Furthermore, the functional inhibition of TRIM30B can be achieved through the modulation of specific signaling pathways. LY294002 and Wortmannin, as inhibitors of the PI3K/Akt pathway, can impede the downstream signaling that involves TRIM30B. PD98059 inhibits the MAPK/ERK pathway, while SB203580 and SP600125 inhibit the p38 MAPK and JNK pathways, respectively. By targeting these pathways, each of these chemicals can contribute to the inhibition of TRIM30B by disrupting the cellular processes in which this protein is known to participate. This comprehensive approach using multiple agents reveals the intricate network of interactions and processes that can be modulated to inhibit the function of TRIM30B.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Proteasome inhibitor that can inhibit the degradation of ubiquitinated proteins, thereby possibly leading to the inhibition of TRIM30B involved in the ubiquitination and subsequent proteasomal degradation pathway.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Lysosomotropic agent that raises the pH in lysosomes, potentially inhibiting the lysosomal degradation of proteins where TRIM30B may be localized for degradation.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Inhibits protein biosynthesis in eukaryotic organisms, possibly leading to inhibition of TRIM30B synthesis in cells where it is actively being produced.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor that can prevent the degradation of proteins involved in the ubiquitin-proteasome pathway, which may include inhibition of proteins that interact with TRIM30B.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$134.00
$215.00
$440.00
$496.00
19
(2)

Selective proteasome inhibitor that could inhibit the degradation of proteins that interact with or regulate TRIM30B, leading to its functional inhibition.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Irreversible proteasome inhibitor that could inhibit the degradation of proteins that modulate TRIM30B activity, therefore inhibiting TRIM30B indirectly.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$72.00
$145.00
$265.00
$489.00
$1399.00
$99.00
19
(3)

Inhibitor of serine, cysteine, and threonine peptidases, which could inhibit the activity of proteases that process proteins interacting with TRIM30B, leading to its inhibition.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K/Akt pathway, which could lead to inhibition of signaling pathways where TRIM30B is involved, thereby inhibiting its function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that can inhibit the MAPK/ERK pathway, possibly leading to inhibition of cellular pathways that involve TRIM30B, resulting in its functional inhibition.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor that could inhibit signaling pathways involving TRIM30B, leading to its functional inhibition.